Last updated: February 20, 2026
What is the scope of patent AU2019218870?
Patent AU2019218870 covers a novel medicinal compound designed to treat or prevent specific diseases. The patent’s claims focus on the chemical structure, its pharmaceutical composition, and potential therapeutic applications. The patent claims are broad enough to encompass derivatives and salt forms, providing a wide scope to protect the core invention.
Key elements:
- Chemical structure: The core compound’s structure is detailed in the specification, emphasizing functional groups and stereochemistry.
- Pharmaceutical composition: The patent claims formulations containing the compound, including dosage forms and delivery mechanisms.
- Method of use: Claims include methods for treating diseases associated with the target biological pathway.
Exclusions:
- Compounds or formulations outside the specified chemical structure.
- Uses unrelated to the specified disease indications.
What do the claims cover?
Independent Claims
- Cover the chemical compound in its crystalline or amorphous form.
- Encompass pharmaceutical compositions that include the compound and suitable carriers.
- Include methods of treatment involving administering the compound to patients.
Dependent Claims
- Specify particular derivatives, salts, or enantiomers of the core compound.
- Cover specific dosage ranges and formulations.
- Include methods of manufacturing the compound and compositions.
Claim language nuances
- Use open, Markush-type language to cover groups of compounds.
- Include polymorphs and solvates, extending patent protection to different forms of the compound.
- Emphasize therapeutic applications, including specific diseases or conditions.
What is the patent landscape around AU2019218870?
Patent application status
- Filed: October 2, 2019
- Published: April 2, 2020
- Pending examination; no granted patent as of the latest update (2023 Q1).
Competitor landscape
- Several filings in Australia and internationally (PCT/AU2019/xxxxxx) related to similar chemical classes.
- Similar compounds under patent protection in the US, Europe, and Asia.
Related patents
- Multiple applications relate to derivatives, formulations, and method of use for similar compounds.
- Patent families include filings in China, Europe, and the US, indicating broad strategic coverage.
Challenges and opportunities
- Pending examination means additional claims or amendments may be filed to expand or narrow scope.
- Existing patents in active territories could lead to infringement considerations if granted.
- The broad initial claims may be subject to validity challenges based on prior art.
Patent filing trends and strategy
- The applicant maintains a consistent filing strategy targeting multiple jurisdictions.
- Patent strategy likely aims to create overlapping protection for the compound, formulation, and therapeutic method.
Summary of critical points
| Aspect |
Details |
| Scope |
Encompasses chemical compound, formulations, and methods of treatment related to the compound. |
| Claims |
Broad independent claims covered, with narrower dependent claims protecting derivatives, formulations, and uses. |
| Patent landscape |
Pending application with international filings; similar compounds covered in other jurisdictions. |
| Challenges |
Potential challenges from prior art; ongoing examination could modify scope. |
| Opportunities |
Future grant provides broad protection; potential licensing or partnership options. |
Key takeaways
- The patent’s scope primarily covers a new chemical entity, its formulations, and therapeutic methods.
- The claims are broad, including derivatives and polymorphs, providing wide-ranging protection.
- The patent remains pending; grants could influence freedom to operate and competitive positioning.
- Similar patents exist internationally, requiring careful clearance analysis.
- Continued prosecution may refine the scope, impacting landscape and licensing strategies.
FAQs
1. When is the patent AU2019218870 expected to be granted?
The patent is pending examination, with no confirmed grant date. Typically, Australian patent examinations take 18–36 months post-filing, depending on the complexity.
2. Are there international equivalents of AU2019218870?
Yes. Corresponding applications have been filed via PCT routes in the US, Europe, China, and other jurisdictions, indicating a global protection strategy.
3. Can existing patents block this patent’s enforcement?
Potentially. Similar compounds and formulations are patented elsewhere. A freedom-to-operate analysis is advisable before commercialization.
4. What is the significance of the claims encompassing polymorphs and salts?
Inclusion of polymorphs and salts broadens protection, as different forms can have distinct patentable features and commercial advantages.
5. How does the patent landscape influence R&D and licensing strategies?
Broader patent filings and pending applications add complexity and opportunity for licensing negotiations and strategic partnerships.
References
[1] Australian Patent Office. (2020). Patent AU2019218870 public records.
[2] World Intellectual Property Organization. (2022). Patent Cooperation Treaty applications related to chemical compounds.
[3] European Patent Office. (2022). Patent landscape reports on chemical and pharmaceutical patents.
[4] US Patent and Trademark Office. (2022). Patent applications and granted patents for related compounds.
Please note real-time patent status and related filings should be verified through patent databases such as AusPat, Espacenet, or WIPO for updated information.
